Skip to content

other

Casgevy

CRISPR-based cell therapy for sickle cell disease, developed by Vertex Pharmaceuticals and CRISPR Therapeutics, that raises fetal hemoglobin levels instead of correcting the beta-globin mutation.

Known aliases

  • exagamglogene autotemcel

Relationships

No evidence-backed relationships are recorded.

Current clusters